Cabazitaxel is a semi-synthetic derivative of the natural Taxoid 10-deacetylbaccatin III with potential antineoplastic activity. Cabazitaxel is used to treat people with prostatecancer that has progressed despite treatment with docetaxel. It was approved by Food and Drug Administration (FDA) in 2010.
SynZeal offers all Cabazitaxel related impuritiesstandards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Cabazitaxel related standards are being used by major pharmaceuticalcompanies across the globe for their ANDA/DMF filing.
.png)
